Transformative Research Services

Understanding the fundamental biological mechanisms of disease is a defining feature of Amgen`s discovery research efforts—and a major contributor to the development of Amgen`s deep and broad pipeline of potential new medicines. Amgen`s "biology first" approach permits its scientists to first explore the complex molecular pathways of disease before determining what type of medicine, or modality, is most likely to deliver optimal efficacy and safety. With the advances in human genetics, Amgen continues to shed new light on the molecular roots of disease. Amgen subsidiary deCODE Genetics, a global leader in human genetics, is a powerful differentiator, greatly improving how we identify and validate human disease targets.